Preclinical evaluation of long-acting cabotegravir and rilpivirine for HIV post-exposure prophylaxis in a macaque modelResearch in context

Summary: Background: Current guidelines for post-exposure prophylaxis (PEP) recommend 28 days of daily oral antiretroviral drugs. However, low adherence and inadequate regimen completion represent important challenges. We investigated in macaques whether a single injection of the combination of lon...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Priya Srinivasan, Jining Zhang, Tiancheng Edwards, Chuong Dinh, Ayanna Green, Dawn Little, Tyana Singletary, Maria Mendoza, Yi Pan, Frank Deyounks, Ryan Johnson, Jonathan Lipscomb, Athena P. Kourtis, Walid Heneine, J. Gerardo García-Lerma, James M. Smith
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2026-01-01
סדרה:	EBioMedicine
נושאים:	HIV post-exposure prophylaxis Macaque models Long-acting injectables Cabotegravir (CAB) Rilpivirine (RPV)
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2352396425005110
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!